CorMedix Inc (CRMD) Stock Analysis

CorMedix Inc (CRMD) is a publicly traded company in the HEALTHCARE sector. It trades at $8.17, carries a market capitalization of $662.92M, a price-to-earnings ratio of 3.89. This page summarizes the public market data, fundamentals, and frequently asked questions for CRMD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.17
• Market Cap: $662.92M
• P/E Ratio: 3.89
• EPS: $2.17
• 52-Week High: $17.43
• 52-Week Low: $6.12

Market Sentiment

CorMedix Inc currently has a Bullish sentiment score of 0.55.

About CorMedix Inc

CorMedix Inc. is a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, specializing in the development and commercialization of innovative therapies for infectious and inflammatory diseases. The company is committed to addressing critical unmet medical needs, particularly in infection control and inflammatory conditions. With a robust pipeline of products aimed at improving patient outcomes, CorMedix is strategically positioned to impact the global healthcare landscape si...

GNG Research Analysis

GNG Research scores CorMedix Inc (CRMD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CRMD.

Frequently Asked Questions

Does CRMD pay dividends?

CorMedix Inc (CRMD) does not currently pay a regular dividend.

What is CRMD's P/E ratio?

CorMedix Inc has a price-to-earnings (P/E) ratio of 3.89.

What is CRMD's market cap?

CorMedix Inc (CRMD) has a market capitalization of $662.92M with a current stock price of $8.17.